Enliven Therapeutics, Inc. ( ELVN) - Stock Earnings
ELVN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -20.1 million USD | — USD |
| 2025Q4 | -29.7 million USD | — USD |
| 2026Q1 | -23.6 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ELVN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -71.6 million USD | — USD |
| 2024 | -89.0 million USD | — USD |
| 2025 | -103.7 million USD | — USD |
| 2026 Est. | — | — |
ELVN
Price: $42.36
52 week price:
Earnings Per Share: -1.64 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.1 billion